Duke Human Vaccine Institute
E10656
The Duke Human Vaccine Institute is a leading research center focused on developing vaccines and immunotherapies for infectious diseases, particularly HIV and emerging pathogens.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Duke Human Vaccine Institute canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T8068 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Duke Human Vaccine Institute Context triple: [School of Medicine, Duke University, hasResearchInstitute, Duke Human Vaccine Institute]
-
A.
Duke Clinical Research Institute
Duke Clinical Research Institute is a leading academic research organization specializing in the design, conduct, and analysis of clinical trials and health outcomes studies across a wide range of medical fields.
-
B.
School of Medicine, Duke University
The School of Medicine at Duke University is a leading U.S. medical school renowned for its research-intensive programs, innovative medical education, and strong clinical partnerships.
-
C.
Duke Cancer Institute
Duke Cancer Institute is a leading comprehensive cancer center at Duke University known for its integrated cancer research, clinical care, and education programs.
-
D.
Wistar Institute
The Wistar Institute is a renowned biomedical research center in Philadelphia known for its pioneering work in cancer, immunology, and vaccine development.
-
E.
Duke University Health System
Duke University Health System is a major academic health care network affiliated with Duke University, providing hospital, clinical, and research services throughout the Durham, North Carolina region.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Duke Human Vaccine Institute Target entity description: The Duke Human Vaccine Institute is a leading research center focused on developing vaccines and immunotherapies for infectious diseases, particularly HIV and emerging pathogens.
-
A.
Duke Clinical Research Institute
Duke Clinical Research Institute is a leading academic research organization specializing in the design, conduct, and analysis of clinical trials and health outcomes studies across a wide range of medical fields.
-
B.
School of Medicine, Duke University
The School of Medicine at Duke University is a leading U.S. medical school renowned for its research-intensive programs, innovative medical education, and strong clinical partnerships.
-
C.
Duke Cancer Institute
Duke Cancer Institute is a leading comprehensive cancer center at Duke University known for its integrated cancer research, clinical care, and education programs.
-
D.
Wistar Institute
The Wistar Institute is a renowned biomedical research center in Philadelphia known for its pioneering work in cancer, immunology, and vaccine development.
-
E.
Duke University Health System
Duke University Health System is a major academic health care network affiliated with Duke University, providing hospital, clinical, and research services throughout the Durham, North Carolina region.
- F. None of above. chosen
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
medical research organization
ⓘ
research center ⓘ vaccine research institute ⓘ |
| affiliation |
Duke University
ⓘ
School of Medicine, Duke University ⓘ
surface form:
Duke University School of Medicine
|
| aimsTo |
develop effective HIV vaccines
ⓘ
improve global access to vaccines ⓘ prepare vaccines for emerging pathogens ⓘ |
| collaboratesWith |
HIV Vaccine Trials Network
ⓘ
National Institutes of Health ⓘ global vaccine research consortia ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| field |
immunology
ⓘ
infectious disease research ⓘ vaccine development ⓘ virology ⓘ |
| focusesOn |
HIV
ⓘ
coronavirus infections ⓘ emerging infectious diseases ⓘ global health ⓘ influenza ⓘ respiratory pathogens ⓘ |
| hasMission |
to develop vaccines and immunotherapies for major infectious diseases
ⓘ
to translate basic immunology discoveries into clinical interventions ⓘ |
| hasResearchInfrastructure |
Biosafety Level 3 laboratory
ⓘ
clinical trials unit ⓘ vaccine production and formulation facilities ⓘ |
| locatedIn | Durham, North Carolina ⓘ |
| partOf |
Duke University Hospital
ⓘ
surface form:
Duke University Medical Center
|
| researchArea |
B cell immunology
ⓘ
T cell immunology ⓘ antibody discovery ⓘ broadly neutralizing antibodies ⓘ clinical vaccine trials ⓘ immune correlates of protection ⓘ immunogen design ⓘ immunotherapies ⓘ monoclonal antibodies ⓘ preclinical vaccine development ⓘ structural biology of viral antigens ⓘ vaccine design ⓘ |
| trains |
graduate students
ⓘ
physician-scientists ⓘ postdoctoral researchers ⓘ |
| typeOfOrganization | nonprofit research institute ⓘ |
| usesMethod |
clinical translational research
ⓘ
structure-based vaccine design ⓘ systems immunology ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Duke Human Vaccine Institute Description of subject: The Duke Human Vaccine Institute is a leading research center focused on developing vaccines and immunotherapies for infectious diseases, particularly HIV and emerging pathogens.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.